For most companies, the honest answer is: nobody knows.
How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...
Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...
Microsoft released TypeScript 6.0 on March 23, the last version built on the original JavaScript codebase, with three post-RC changes and a wave of deprecations designed to ready codebases for the ...
On March 31, 2026, the popular HTTP client Axios experienced a supply chain attack, causing two newly published npm packages ...
Adam Hayes, Ph.D., CFA, is a financial writer with 15+ years Wall Street experience as a derivatives trader. Besides his extensive derivative trading expertise, Adam is an expert in economics and ...
Lysosomes are dynamic organelles that receive membrane traffic input from the secretory, endocytic, autophagic and phagocytic pathways. They can also fuse with the plasma membrane. Live-cell imaging ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results